The carcinogen, 7-hydroxymethyl-12-methylbenz[a]anthracene, is activated and covalently binds to DNA via a sulphate ester
- 15 August 1985
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (16) , 3002-3005
- https://doi.org/10.1016/0006-2952(85)90031-0
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Covalent binding of the proximate carcinogen, 7-hydroxymethyl-12-methylbenz[a]anthracene (7-HMBA) to rat liver cytosolic protein via 7-HMBA sulphateBiochemical Pharmacology, 1983
- Acetylation, deacetylation and acyltransferEnvironmental Health Perspectives, 1983
- Conjugation of 7-hydroxymethyl-12-methylbenz[a]anthracene (7-HMBA) with glutathione via a sulphate ester in hepatic cytosolBiochemical Pharmacology, 1982
- Covalent binding of N-hydroxy-Trp-P-2 to DNA by cytosolic proline-dependent systemBiochemical and Biophysical Research Communications, 1982
- A 7-Hydroxymethyl Sulfate Ester as an Active Metabolite of 7,12-Dimethylbenz[ a ]anthraceneScience, 1982
- Nitroxide radicals generated from carcinogenic aminoazo dyes during their metabolism in vivo and in enzymatic system in vitroBiochemical Pharmacology, 1979
- Metabolic Activation ofN-Hydroxy Compounds by ConjugationXenobiotica, 1971
- Reactivity in vivo of the Carcinogen N -Hydroxy-2-acetylaminofluorene: Increase by Sulfate IonScience, 1970
- Induction of Adrenal Damage and Cancer with Metabolites of 7,12-Dimethylbenz(a)AnthraceneNature, 1965
- SELECTIVE ADRENAL NECROSIS AND APOPLEXY INDUCED BY 7,12-DIMETHYLBENZ(a)ANTHRACENEThe Journal of Experimental Medicine, 1961